Showing results (651-660 of 683) with videos related to

Sort By:
Pageof 69
Frontiers in Global Women'S Health|October 27, 2022
Advancing maternal and perinatal health in low- and middle-income countries: A multi-country review of policies and programmesUzma Syed, Mary V Kinney, Ekaterine Pestvenidze, et al.
Trials|May 14, 2024
Targeting strategies for balanced energy and protein (BEP) supplementation in pregnancy: study protocol for the TARGET-BEP cluster-randomized controlled trial in rural BangladeshEleonor Zavala, Diwakar Mohan, Hasmot Ali, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 6, 2015
Augmentation of CFTR maturation by S-nitrosoglutathione reductaseKhalequz Zaman, Victoria Sawczak, Atiya Zaidi, et al.
JPMA. the Journal of the Pakistan Medical Association|April 22, 2026
Pakistan's national hepatitis strategic framework (2024-2030)Hassan Mahmood, Ahmed Sabry Alaama, Muhammad Shahid Jamil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlatesJanelle M Meyer, Kelly S Perlewitz, James B Hayden, et al.
Skeletal Muscle|November 27, 2013
Rb1 loss modifies but does not initiate alveolar rhabdomyosarcomaKen Kikuchi, Eri Taniguchi, Hung-I Harry Chen, et al.
Nature Communications|June 8, 2021
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinomaAyana T Ruffin, Anthony R Cillo, Tracy Tabib, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal MetastasisAmal T Elhaw, Priscilla W Tang, Ya-Yun Cheng, et al.
Advances in Radiation Oncology|July 26, 2017
Patient-reported distress and survival among patients receiving definitive radiation therapyYacob Habboush, Robert P Shannon, Shehzad K Niazi, et al.
Cancer Research|April 16, 2026
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal MetastasisAmal T Elhaw, Priscilla W Tang, Ya-Yun Cheng, et al.
Pageof 69